Invivyd Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Invivyd Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Invivyd Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Invivyd Inc. is IVVD:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Invivyd Inc. has its primary listing on NASDAQ. You can trade Invivyd Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Invivyd Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Invivyd Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Invivyd Inc..